Roles and mechanism of natural killer cells in clinical and experimental transplantation

References

• Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J. Exp. Med.203(8), 1851–1858 (2006).
   PubMed Web of Science ®Google Scholar
• Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol. Rev.4, 130–142 (2006).
   Google Scholar
• Murphy WJ, Koh CY, Raziuddin A, Bennett M, Longo DL. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol. Rev.181, 279–289 (2001).
   PubMed Web of Science ®Google Scholar
• Anfossi N, Andre P, Guia S et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity25(2), 331–342 (2006).
   PubMed Web of Science ®Google Scholar
• Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin. Exp. Immunol.149(1), 1–8 (2007).
   PubMed Web of Science ®Google Scholar
• Beelen DW, Ottinger HD, Ferencik S et al. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood105(6), 2594–2600 (2005).
   PubMedGoogle Scholar
• Stet RJ, Hermsen T, Westphal AH et al. Novel immunoglobulin-like transcripts in teleost fish encode polymorphic receptors with cytoplasmic ITAM or ITIM and a new structural Ig domain similar to the natural cytotoxicity receptor NKp44. Immunogenetics57(1–2), 77–89 (2005).
   PubMedGoogle Scholar
• Tha-In T, Metselaar HJ, Tilanus HW et al. Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood110(9), 3253–3262 (2007).
   PubMed Web of Science ®Google Scholar
• Forte P, Lilienfeld BG, Baumann BC, Seebach JD. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J. Immunol.175(8), 5463–5470 (2005).
   PubMedGoogle Scholar
• Graham CM, Christensen JR, Thomas DB. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-γ? Immunology121(2), 238–247 (2007).
   PubMedGoogle Scholar
• Gonzalez-Hernandez Y, Pedraza-Sanchez S, Blandon-Vijil V et al. Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-γ. Scand. J. Immunol.65(4), 368–375 (2007).
   Google Scholar
• Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science285(5428), 727–729 (1999).
   PubMed Web of Science ®Google Scholar
• Ortaldo JR, Mason AT, Winkler-Pickett R, Raziuddin A, Murphy WJ, Mason LH. Ly-49 receptor expression and functional analysis in multiple mouse strains. J. Leukoc. Biol.66(3), 512–520 (1999).
   PubMedGoogle Scholar
• Braud VM, Allan DS, Wilson D, McMichael AJ. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol.8, 1–10 (1998).
   PubMedGoogle Scholar
• Adang LA, Tomescu C, Law WK, Kedes DH. Intracellular Kaposi’s sarcoma-associated herpesvirus load determines early loss of immune synapse components. J. Virol.81(10), 5079–5090 (2007).
   PubMedGoogle Scholar
• Xie X, Dighe A, Clark P, Sabastian P, Buss S, Brown MG. Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J. Virol.81(1), 229–236 (2007).
   PubMedGoogle Scholar
• Moretta A. Molecular mechanisms in cell-mediated cytotoxicity. Cell90(1), 13–18 (1997).
   PubMed Web of Science ®Google Scholar
• Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature419(6908), 734–738 (2002).
   PubMed Web of Science ®Google Scholar
• Sutherland CL, Chalupny NJ, Cosman D. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev.181, 185–192 (2001).
   PubMed Web of Science ®Google Scholar
• Parolini S, Bottino C, Falco M et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein–Barr virus-infected cells. J. Exp. Med.192, 337–346 (2000).
   PubMed Web of Science ®Google Scholar
• Philips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science268, 403–405 (1995).
   PubMedGoogle Scholar
• Mingari MC, Schiavetti F, Ponte M et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Procl. Natl Acad. Sci. USA93, 12433–12438 (1996).
   PubMedGoogle Scholar
• Reyburn H, Mandelboim O, Valés-Goméz M et al. Human NK cells; their ligands, receptors and functions. Immunol. Rev.155, 119–125 (1997).
   PubMed Web of Science ®Google Scholar
• Coles MC, McMahon CW, Takisawa H, Raulet DH. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly 49 receptors. Eur. J. Immunol.30, 236–244 (2000).
   PubMedGoogle Scholar
• Colonna M, Nkajima H, Cella M. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells. J. Leukoc. Biol.66, 718–722 (1999).
   PubMed Web of Science ®Google Scholar
• Lepin EJ, Bastin JM, Allan DS et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur. J. Immunol.30, 3552–3561 (2000).
   PubMedGoogle Scholar
• French AR,Yokoyama WM. Natural killer cells and autoimmunity. Arthritis Res. Ther.6, 8–14 (2004).
   PubMed Web of Science ®Google Scholar
• Valiante NM, Uhrberg M, Shilling HG et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity7, 739–751 (1997).
   PubMed Web of Science ®Google Scholar
• Held W, Dorfman JR, Wu MF, Raulet DH. Major histocompatibility complex class-I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol.26, 286–2292 (1996).
   Google Scholar
• Grzywacz B, Kataria N, Sikora M et al. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood108(12), 3824–3833 (2006).
   PubMed Web of Science ®Google Scholar
• Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol.5, 996–1002 (2004).
   PubMed Web of Science ®Google Scholar
• Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achie achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood105, 4416–4423 (2005).
   PubMed Web of Science ®Google Scholar
• Wu MF, Raulet DH. Class I-deficient hematopoietic cells and nonhematopoietic cells dominantly induce unresponsiveness of NK cells to class I-deficient bone marrow grafts. J. Immunol.158, 1628–1633 (1997).
   PubMedGoogle Scholar
• Johansson MH, Bieberich C, Jay G, Karre K, Hoglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex I transgene. J. Exp. Med.186, 353–364 (1997).
   PubMed Web of Science ®Google Scholar
• McNerney ME, Guzior D, Kumar V. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice. Blood106(4), 1337–1340 (2005).
   PubMedGoogle Scholar
• Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiantiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol.17, 189–220 (1999).
   PubMed Web of Science ®Google Scholar
• Raulet DH, Vance RE, McMohan CW. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol.19, 291–330 (2001).
   PubMedGoogle Scholar
• Johansson S, Johansson M, Rosmaraki et al. Natural killer cell eduction in mice with single or multiple major histocompatibiltiy complex class I molecules. J. Exp Med.201, 1145–1155 (2005).
   PubMedGoogle Scholar
• Poirot L, Benoist C, Mathis D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl Acad. Sci. USA101, 8102 –8107 (2004).
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science295, 2097–2100 (2002).
   PubMed Web of Science ®Google Scholar
• Afzali B, Lechler RI, Hernandez-Fuentes MP. Allorecognition and the alloresponse: clinical implications. Tissue Antigens69(6), 545–556 (2007).
   PubMedGoogle Scholar
• Petersdorf E, Anasetti C, Martin PJ et al. Genomics of unrelated-donor hematopoietic cell transplantation. Curr. Opin. Immunol.13(5), 582–589 (2001).
   PubMedGoogle Scholar
• Zhao XY, Huang XJ, Liu KY, Xu LP, Liu DH. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients. Eur. J. Haematol.78(4), 338–346 (2007).
   PubMedGoogle Scholar
• Zhao XY, Huang XJ, Liu KY, Xu LP, Liu DH. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome. Biol. Blood Marrow Transplant.13(6), 734–744 (2007).
   PubMedGoogle Scholar
• Sobecks RM, Ball EJ, Maciejewski JP et al. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors. Bone Marrow Transplant.39(7), 417–424 (2007).
   PubMedGoogle Scholar
• Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J. Exp. Med.134(6), 1513–1528 (1971).
   PubMed Web of Science ®Google Scholar
• Suzue K, Reinherz EL, Koyasu S. Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice. Eur. J. Immunol.31(11), 3147–3152 (2001).
   Google Scholar
• Raziuddin A, Longo DL, Bennett M, Winkler-Pickett R, Ortaldo JR, Murphy WJ. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Blood100(8), 3026–3033 (2002).
   PubMedGoogle Scholar
• Lee LA, Sergio JJ, Sykes M. Natural killer cells weakly resist engraftment of allogeneic, long term, multilineage hematopoirtic stem cells. Transplantation61, 125–132 (1996).
   PubMedGoogle Scholar
• Han M, Fallena M, Guo Y, Stastny P. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands. Hum. Immunol.68 (6), 507–513 (2007).
   PubMedGoogle Scholar
• Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A. Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. Cytotherapy8(6), 554–558 (2006).
   PubMed Web of Science ®Google Scholar
• Murphy WJ, Longo DL. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. Immunol. Rev.157, 167–176 (1997).
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Martelli MF, Velardi A. Cellular therapy, exploiting NK cell alloreactivity in transplantation. Curr. Opin. Hematol.8, 355–359 (2001).
   PubMed Web of Science ®Google Scholar
• Hamby K, Trexler A, Pearson TC, Larsen CP, Rigby MR, Kean LS. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism. Am. J. Transplant.7(8), 1884–1896 (2007).
   PubMedGoogle Scholar
• Markus PM, Selvaggi G, Cai X, Fung JJ, Starzl TE. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B–>A) in rats. Cell Transplant.2(4), 345–353 (1993).
   PubMed Web of Science ®Google Scholar
• Shelton MW, Walp LA, Basler JT, Uchiyama K, Hanto DW. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells. Transplantation54(2), 278–286 (1992).
   PubMedGoogle Scholar
• Bingaman AW, Ha J, Waitze SY et al. Vigorous allograft rejection in the absence of danger. J. Immunol.164(6), 3065–3071 (2000).
   PubMed Web of Science ®Google Scholar
• Zijlstra M, Auchincloss H Jr, Loring JM, Chase CM, Russell PS, Jaenisch R. Skin graft rejection by β2-microglobulin-deficient mice. J. Exp. Med.175(4), 885–893 (1992).
   PubMed Web of Science ®Google Scholar
• Beilke JN, Gill RG. Frontiers in nephrology: the varied faces of natural killer cells in transplantation – contributions to both allograft immunity and tolerance. J. Am. Soc. Nephrol.18(8), 2262–2267 (2007).
   PubMedGoogle Scholar
• Maurus CF, Schneider MK, Schmidt D, Zund G, Seebach JD. Activation of human microvascular endothelial cells with TNF-α and hypoxia/reoxygenation enhances NK-cell adhesion, but not NK-cytotoxicity. Transplantation81(8), 1204–1211 (2006).
   PubMedGoogle Scholar
• Kitchens WH, Uehara S, Chase CM, Colvin RB, Russell PS, Madsen JC. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation81(6), 811–817 (2006).
   PubMedGoogle Scholar
• Kondo T, Morita K, Watarai Y et al. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation69(5), 969–977 (2000).
   PubMedGoogle Scholar
• Obara H, Nagasaki K, Hsieh CL et al. IFN-γ, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am. J. Transplant.5(9), 2094–2103 (2005).
   PubMedGoogle Scholar
• Baldwin WM 3rd, Larsen CP, Fairchild RL. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity14(4), 369–376 (2001).
   PubMedGoogle Scholar
• Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med.195(3), 327–333 (2002).
   PubMed Web of Science ®Google Scholar
• McDouall RM, Batten P, McCormack A, Yacoub MH, Rose ML. MHC class II expression on human heart microvascular endothelial cells: exquisite sensitivity to interferon-γ and natural killer cells. Transplantation64(8), 1175–1180 (1997).
   PubMed Web of Science ®Google Scholar
• Watson CA, Petzelbauer P, Zhou J, Pardi R, Bender JR. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-γ-dependent and -independent mechanisms. J. Immunol.154(7), 3222–3233 (1995).
   PubMedGoogle Scholar
• Kim S, Poursine-Laurent J, Truscott SM et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature436(7051), 709–713 (2005).
   PubMed Web of Science ®Google Scholar
• Magalhaes-Silverman M, Donnenberg A, Lembersky B et al. Post transplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast Cancer J. Immunother.23, 154–160 (2000).
   Google Scholar
• Koenecke C, Shaffer J, Alexander SI et al. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507. Exp. Hematol.31, 911–923 (2003).
   PubMedGoogle Scholar
• Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol.20, 323–370 (2002).
   PubMed Web of Science ®Google Scholar
• López-Alvarez MR, Gómez-Mateo J, Ruiz-Merino G et al. Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients. Transpl. Immunol.17(1), 51–54 (2006).
   PubMedGoogle Scholar
• Kruit WH, Goey SH, Lamers CH et al. High-dose regimen of interleukin-2 and interferon-α in combination with lymphokine-activated killer cells in patients with metastatic renal cell cancer. J. Immunother.20, 312–320 (1997).
   PubMed Web of Science ®Google Scholar
• Cortes JE, Kantarjian HM, O’Brien S et al. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission. Cancer85, 1506–1513 (1999).
   PubMed Web of Science ®Google Scholar
• Yen JH, Moore BE, Nakajima T et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med.193(10), 1159–1167 (2001).
   PubMed Web of Science ®Google Scholar
• Ayalon O, Hughes EA, Cresswell P et al. Induction of transporter associated with antigen processing by interferon γ confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc. Natl Acad. Sci. USA95(5), 2435–2440 (1998).
   PubMedGoogle Scholar
• Uehara S, Chase CM, Kitchens WH et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J. Immunol.175(5), 3424–3430 (2005).
   PubMedGoogle Scholar
• Kimura H, Yamaguchi Y. A Phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or non-curative resection of primary lung carcinoma. Cancer80, 42–49 (1997).
   PubMed Web of Science ®Google Scholar
• Aguila HL, Weissman IL. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells.Blood87, 1225–1231 (1996).
   PubMedGoogle Scholar
• Fischer JC, Ottinger H, Ferencik S et al. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J. Immunol.178(6), 3918–3923 (2007).
   PubMedGoogle Scholar
• Petersson E, Ostraat O, Ekberg H et al. Allogeneic heart transplantation activates alloreactive NK cells. Cell. Immunol.175(1), 25–32 (1997).
   PubMedGoogle Scholar
• Cooper MA, Fehniger TA, Turner SC et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood97(10), 3146–51 (2001).
   PubMed Web of Science ®Google Scholar
• Lima M, Teixeira MA, Queirós ML et al. Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol. Dis.27(4), 731–43 (2001).
   PubMed Web of Science ®Google Scholar
• Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE. CD16- CD56+ natural killer cells after bone marrow transplantation. Blood79(12), 3239–3244 (1992).
   PubMed Web of Science ®Google Scholar
• Ouyang Q, Baerlocher G, Vulto I, Lansdorp PM. Telomere length in human natural killer cell subsets. Ann. NY Acad. Sci.1106, 240–252 (2007).
   PubMedGoogle Scholar
• Romagnani C, Juelke K, Falco M et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol.178(8), 4947–4955 (2007).
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood94(1), 333–339 (1999).
   PubMed Web of Science ®Google Scholar
• Rhoades JL, Cibull ML, Thompson JS et al. Role of natural killer cell in the pathogenesis of human acute graft-versus –host disease. Transplantation56(1), 113–120 (1993).
   PubMedGoogle Scholar
• Wang JW, Howson JM, Ghansah T et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science295(5562), 2094–2097 (2002).
   PubMed Web of Science ®Google Scholar
• Wang H, Grzywacz B, Sukovich D, McCullar V et al. The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood110(5), 1530–1539 (2007).
   PubMedGoogle Scholar
• Benlagha K, Kyin T, Beavis A et al. A thymic precursor to the NK T cell lineage. Science296, 553–555 (2002).
   PubMed Web of Science ®Google Scholar
• Emoto M, Kaufmann SHE. Liver NKT cells, an account of heterogeneity. Trends Immunol.24, 364–369 (2003).
   PubMed Web of Science ®Google Scholar
• Chen H, Paul WE. Cultured NK1.11CD41T cells produce large amounts of IL-4 and IFNγ upon activation by anti-CD3 or CD1. J. Immunol.159, 2240 (1997).
   PubMed Web of Science ®Google Scholar
• Daniels KA, Devora G, Lai WC, O’Donnell CL, Bennett M, Welsh RM. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med.194(1), 29–44 (2001).
   PubMedGoogle Scholar
• Zeng D, Lewis D, Dejbakhsh-Jones S et al. Bone marrow NK1.1 (-) and NK1.1 (+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med.189, 1073–1081 (1999).
   PubMed Web of Science ®Google Scholar
• Ikehara Y, Yasunami Y, Kodama S et al. CD41Va14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest.105, 1761–1767 (2000).
   PubMed Web of Science ®Google Scholar
• Seino K, Fukao K, Muramoto K et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl Acad. Sci. USA98, 2577–2581 (2001).
   PubMed Web of Science ®Google Scholar
• Li L, Huang L, Sung SS et al. NKT cell activation mediates neutrophil IFN-γ production and renal ischemia–reperfusion injury. J. Immunol.178, 5899–5911 (2007).
   PubMed Web of Science ®Google Scholar